Taiwan Biomaterial , Ltd. (6649.TWO) has a profit margin of 5.23%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for 6649.TWO is 5.23% as of September 2026. That compares with 27.98% in the prior-year period — down 81.3% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Taiwan Biomaterial , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 6649.TWO's profit margin moved from 27.98% to 5.23% — a 81.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Taiwan Biomaterial , Ltd.'s valuation or profitability profile.
Against its sector companies, 6649.TWO currently prints 5.23% for profit margin, while the sector average sits near 13.4%. That is roughly 61.0% below the sector mean. Large gaps often invite a closer look at Taiwan Biomaterial , Ltd.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Taiwan Biomaterial , Ltd. converts resources into returns. At 5.23%, 6649.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 27.98% in the prior-year period — down 81.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 6649.TWO's profit margin (5.23%), review year-over-year change from 27.98%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.